Key Insights

Highlights

Treatment Research

2 treatments under study, led by Aspirin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07195149Phase 3Recruiting

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Showing all 1 trials

Research Network

Common Treatments

  • Aspirin1
  • Dapt Lowdose Aspirin 75 Mg Prasugrel 10 Mg1

Active Sponsors

  • Medical Research Agency, Poland1
  • Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1
  • Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o.1

Top Investigators

Related Conditions

  • Stable Coronary Artery Disease Cad1
  • Chronic Coronary Syndrome1

Activity Timeline